Home  

Enter a class name or drug name above to search the database.

Increased Erythroid Cell Production [PE]

NDC Number Brand Name Generic Name Labeler Dosage Form DEA Schedule Marketing Start Date
55513-002 ARANESP darbepoetin alfa Amgen Inc SOLUTION 2006-09-11
55513-003 ARANESP darbepoetin alfa Amgen Inc SOLUTION 2006-09-11
55513-004 ARANESP darbepoetin alfa Amgen Inc SOLUTION 2006-09-11
55513-005 ARANESP darbepoetin alfa Amgen Inc SOLUTION 2006-09-11
55513-006 ARANESP darbepoetin alfa Amgen Inc SOLUTION 2006-09-11
55513-021 ARANESP darbepoetin alfa Amgen Inc INJECTION, SOLUTION 2006-08-14
55513-023 ARANESP darbepoetin alfa Amgen Inc INJECTION, SOLUTION 2006-08-14
55513-025 ARANESP darbepoetin alfa Amgen Inc INJECTION, SOLUTION 2006-08-14
55513-027 ARANESP darbepoetin alfa Amgen Inc INJECTION, SOLUTION 2006-09-11
55513-028 ARANESP darbepoetin alfa Amgen Inc INJECTION, SOLUTION 2006-08-14
55513-032 ARANESP darbepoetin alfa Amgen Inc INJECTION, SOLUTION 2006-06-07
55513-057 ARANESP darbepoetin alfa Amgen Inc INJECTION, SOLUTION 2006-08-26
55513-098 ARANESP darbepoetin alfa Amgen Inc INJECTION, SOLUTION 2006-08-26
55513-111 ARANESP darbepoetin alfa Amgen Inc INJECTION, SOLUTION 2006-08-14
59572-711 Reblozyl Luspatercept Celgene Corporation INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 2019-11-08
59572-775 Reblozyl Luspatercept Celgene Corporation INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 2019-11-08

 Physiological Effect (PE) Classification 

Loading full table content...